Sara N. Horst

Keith T. Wilson2
Caroline T. Brown2
Margaret M. Allaman2
James C. Slaughter2
2Keith T. Wilson
2Caroline T. Brown
2Margaret M. Allaman
Learn More
Inflammatory bowel diseases, ulcerative colitis and Crohn’s disease are considered to be of autoimmune origin, but the etiology of irritable bowel syndrome remains elusive. Furthermore, classifying patients into irritable bowel syndrome and inflammatory bowel diseases can be difficult without invasive testing and holds important treatment implications. Our(More)
  • Lori A. Coburn, Sara N. Horst, Rupesh Chaturvedi, Caroline T. Brown, Margaret M. Allaman, Brooks P. Scull +10 others
  • 2013
Accurate and high-throughput technologies are needed for identification of new therapeutic targets and for optimizing therapy in inflammatory bowel disease. Our aim was to assess multi-analyte protein-based assays of cytokines/chemokines using Luminex technology. We have reported that Luminex-based profiling was useful in assessing response to L-arginine(More)
  • Dawn M. Wiese, Sara N. Horst, Caroline T. Brown, Margaret M. Allaman, Mallary E. Hodges, James C. Slaughter +5 others
  • 2016
BACKGROUND AND AIMS Ulcerative colitis (UC) is associated with increased dietary intake of fat and n-6 polyunsaturated fatty acids (PUFA). Modification of fat metabolism may alter inflammation and disease severity. Our aim was to assess differences in dietary and serum fatty acid levels between control and UC subjects and associations with disease activity(More)
  • 1